| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL AND ETHINYL ESTRADIOL | 28 |
| 1 | ACETAMINOPHEN | 6 |
| 2 | ASPIRIN | 6 |
| 3 | ASPIRIN 325 MG | 6 |
| 4 | ASPIRIN 81 MG | 6 |
| 5 | LEVOTHYROXINE SODIUM | 5 |
| 6 | PREDNISONE | 5 |
| 7 | UPADACITINIB | 5 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 4 |
| 9 | ERGOCALCIFEROL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PALIFERMIN | 1 | 0.0026 |
| 1 | ETONOGESTREL AND ETHINYL ESTRADIOL | 28 | 0.0013 |
| 2 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 3 | ESTRADIOL/NORETHINDRONE ACETATE | 2 | 0.0010 |
| 4 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 5 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 6 | VANDETANIB | 1 | 0.0006 |
| 7 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 8 | PRASTERONE | 1 | 0.0004 |
| 9 | DEXMEDETOMIDINE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 31 |
| 1 | Progestin [EPC] | 28 |
| 2 | Corticosteroid [EPC] | 10 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 6 |
| 5 | Janus Kinase Inhibitor [EPC] | 5 |
| 6 | Expectorant [EPC] | 4 |
| 7 | Insulin Analog [EPC] | 4 |
| 8 | Loop Diuretic [EPC] | 4 |
| 9 | Proton Pump Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Estrogen [EPC] | 31 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 4 | Progestin [EPC] | 28 | 0.0001 |
| 5 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 6 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 8 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 9 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |